ArticleNPJ digital medicine2026
Towards generalizable seizure monitoring: EpiVLM for cross-environment detection and classification.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The translation of automated seizure detection from controlled clinical units to real-world settings is hindered by heterogeneous recording conditions and limited expert monitoring. We introduce EpiVLM, a multimodal vision-language system that combines clinically structured prompts with video reasoning for cross-environment seizure monitoring. Evaluated on a robust and diverse dataset of 232 video recordings from 127 patients, totaling 11,666 expert-annotated segments from two tertiary centers, unconstrained home recordings, and an independent public dataset, EpiVLM recognized five major semiologies with accuracy 0.795-0.947 and sensitivity 0.842-0.957. With prompts and decision thresholds fixed a priori, performance remained consistent across diverse real-world acquisition conditions without site-specific recalibration. In external validation sets, EpiVLM sustained strong recognition while maintaining low video-level false detections (0.47-2.45%) and timely detection (mean onset-to-detection delay <6 s). Compared with standard video deep-learning baselines, EpiVLM achieved superior overall performance. These results support scalable seizure recognition from routine video and motivate prospective evaluation for remote outcome monitoring.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.